Proteomics profiling of colorectal cancer progression identifies PLOD2 as a potential therapeutic target

Detalles Bibliográficos
Autores principales: Shao, Yingkuan, Xu, Kailun, Zheng, Xi, Zhou, Biting, Zhang, Xiuli, Wang, Lin, Sun, Yaoting, Li, Dan, Chen, Ting, Wang, Jian, Yu, Shaojun, Sun, Lifeng, Xu, Xiaoming, Dai, Shaozhi, Gao, Huanhuan, Ruan, Guan, Liu, Wei, Cai, Xue, Zhu, Tiansheng, Qi, Lina, Chen, Jiani, Hu, Wangxiong, Weng, Xingyue, Zhu, Yi, Xiang, Xueping, Hu, Zhiyuan, Li, Jinfan, Chen, Lirong, Shao, Jimin, Zheng, Shu, Guo, Tiannan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822592/
https://www.ncbi.nlm.nih.gov/pubmed/34862750
http://dx.doi.org/10.1002/cac2.12240
Descripción
Sumario:

Ejemplares similares